SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Caplin Point Lab reports Profit after tax of Rs 575.10 Mln, in the September 2022 quarter

12 Nov 2022 Evaluate
Net sales declined -14.62%  to  Rs. 1369.50 million from Rs. 1604.00 millions.Net profit declined -11.74% to Rs. 575.10 millions from Rs. 651.60 millions.The company reported a degrowth in operating Profit to 798.70 millions from 898.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1369.50 1604.00 -14.62 2533.40 2879.00 -12.00 5280.60 4826.80 9.40
Other Income 224.50 184.20 21.88 574.20 377.50 52.11 565.50 186.20 203.71
PBIDT 798.70 898.20 -11.08 1609.50 1654.60 -2.73 2761.70 2325.50 18.76
Interest 0.40 0.20 100.00 0.50 0.50 0.00 0.90 1.70 -47.06
PBDT 798.30 898.00 -11.10 1609.00 1654.10 -2.73 2760.80 2323.80 18.81
Depreciation 65.10 63.10 3.17 128.80 125.10 2.96 257.70 224.40 14.84
PBT 733.20 834.90 -12.18 1480.20 1529.00 -3.19 2503.10 2099.40 19.23
TAX 158.10 183.30 -13.75 272.70 331.90 -17.84 624.40 537.10 16.25
Deferred Tax -17.10 2.80 -710.71 -45.10 5.10 -984.31 8.20 -11.70 -170.09
PAT 575.10 651.60 -11.74 1207.50 1197.10 0.87 1878.70 1562.30 20.25
Equity 151.60 151.30 0.20 151.60 151.30 0.20 151.60 151.30 0.20
PBIDTM(%) 58.32 56.00 4.15 63.53 57.47 10.54 52.30 48.18 8.55

Caplin Point Lab Share Price

1772.50 6.05 (0.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×